Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II–III breast cancer? A multicentre retrospective study (KROG 12-05)-Reference-Cited by-同舟云学术

Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II–III breast cancer? A multicentre retrospective study (KROG 12-05)

Published:2014-01-30 Issue:6 Volume:110 Page:1420-1426
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Noh J M,Park W,Suh C-O,Keum K C,Kim Y B,Shin K H,Kim K,Chie E K,Ha S W,Kim S S,Ahn S D,Shin H S,Kim J H,Lee H-S,Lee N K,Huh S J,Choi D H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201426.pdf

Reference23 articles.

1. Bear HD, Anderson S, Brown A, Smith R, Mamounas EP, Fisher B, Margolese R, Theoret H, Soran A, Wickerham DL, Wolmark N (2003) The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 21: 4165–4174.

2. Boughey JC, Donohue JH, Jakub JW, Lohse CM, Degnim AC (2010) Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors. Cancer 116: 3322–3329.

3. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA (2004) Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22: 2303–2312.

4. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378: 1707–1716.

5. Daveau C, Stevens D, Brain E, Berges O, Villette S, Moisson P, Gardner M, De la Lande B, Lasry S, Labib A, Le Scodan R (2010) Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy? Int J Radiat Oncol Biol Phys 78: 337–342.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring neoadjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGICC) consensus and recommendations;Cancer;2024-07-10

2. Consenso de la Sociedad Española de Senología y Patología Mamaria (SESPM) sobre la biopsia selectiva del ganglio centinela (BSGC) y el manejo axilar en el cáncer de mama (2022);Revista de Senología y Patología Mamaria;2022-10

3. Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy;Current Problems in Surgery;2022-09

4. Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?;JAMA Oncology;2022-06-01

5. Regional Nodal Irradiation Considerations in Patients Receiving Neoadjuvant Systemic Therapy;Management of the Breast and Axilla in the Neoadjuvant Setting;2021-12-15